Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00899912 · ClinicalTrials.gov registry record
Changes in DNA After Radiation Therapy in Patients With Prostate Cancer
A clinical trial, sponsored by Radiation Therapy Oncology Group.
- Completed
- Registry status
- 13
- Enrollment target
NCT00899912 is a clinical trial that has completed, run by Radiation Therapy Oncology Group. The registered enrollment target is 13 participants.
The verdict
NCT00899912 has completed, sponsored by Radiation Therapy Oncology Group.
- COMPLETED
- Registry status
- 13 participants
- Enrollment target
Study Summary
RATIONALE: Collecting and storing samples of tissue from patients with cancer to study in the laboratory may help doctors learn more about changes that may occur in DNA after radiation therapy and identify biomarkers related to cancer. PURPOSE: This laboratory study is looking at changes in DNA after radiation therapy in patients with prostate cancer.
Interventions
- GENETIC microarray analysis
- OTHER diagnostic laboratory biomarker analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 13 participants |
| Start Date | 2006-06 |
| Est. Completion | 2013-11 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00899912
The ClinicalTrials.gov registry entry for NCT00899912 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 13 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Radiation Therapy Oncology Group, which has 144 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which microarray analysis is the first listed.
NCT00899912 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00899912 about?
NCT00899912 is a clinical study titled "Changes in DNA After Radiation Therapy in Patients With Prostate Cancer". RATIONALE: Collecting and storing samples of tissue from patients with cancer to study in the laboratory may help doctors learn more about changes that may occur in DNA after radiation therapy and identify biomarkers related to cancer. PURPOSE: This laboratory study is looking at changes in DNA aft...
What is the current status of trial NCT00899912?
This trial is currently completed. The enrollment target is 13 participants. The study started on 2006-06. Estimated completion is 2013-11.
What interventions are being tested in trial NCT00899912?
The interventions under investigation include: microarray analysis (GENETIC), diagnostic laboratory biomarker analysis (OTHER).
Who is sponsoring clinical trial NCT00899912?
This trial is sponsored by Radiation Therapy Oncology Group, which has 144 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.